GlassScriptPhysician profile
Marilyn Frances Velez
NPI 1861877839
$7,689.64
in general payments reported to CMS, 2019-2025
54 companies · $2,036 in 2025
The $2,036 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,510 · 2022: $1,874 · 2023: $1,432 · 2024: $838 · 2025: $2,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,289 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,289.12 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,138.70 | 2021-2023 | Fasenra, Breztri, Bevespi Aerosphere |
| Boehringer Ingelheim Pharmaceuticals, INC. | $565.88 | 2021-2025 | Jardiance, Ofev |
| Novo Nordisk INC | $367.09 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $354.20 | 2021-2023 | Glassia, Cuvitru |
| Actelion Pharmaceuticals US, INC. | $293.80 | 2021-2023 | Uptravi, Opsumit |
| Grifols USA, LLC | $285.40 | 2021-2023 | Prolastin-C Liquid |
| Genzyme Corporation | $265.22 | 2021-2023 | |
| Glaxosmithkline, LLC. | $255.16 | 2021-2023 | Trelegy Ellipta |
| Amgen INC. | $243.87 | 2022-2025 | Tepezza, Repatha, Evenity |
| Regeneron Healthcare Solutions, INC. | $236.66 | 2021-2023 | Dupixent |
| Pulmonx Corporation | $220.23 | 2022-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Medtronic, INC. | $186.54 | 2024-2025 | Minimed 780g |
| Bayer Healthcare Pharmaceuticals INC. | $177.72 | 2022-2025 | |
| Dexcom, INC. | $175.24 | 2024-2025 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $171.32 | 2021-2023 | Yupelri |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $161.29 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Sanofi-Aventis U.S. LLC | $150.67 | 2024-2025 | |
| Harmony Biosciences LLC | $148.33 | 2021-2023 | Wakix |
| Lilly USA, LLC | $143.67 | 2024-2025 | Jardiance, Mounjaro |
| Cequr Corporation | $141.08 | 2025 | Cequr Simplicity |
| Radius Health, INC. | $139.40 | 2024-2025 | Tymlos |
| Recordati_rare_diseases_inc. | $135.84 | 2024-2025 | Isturisa |
| Insmed, INC. | $126.66 | 2022-2023 | Arikayce |
| United Therapeutics Corporation | $124.60 | 2021-2023 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $114.29 | 2021-2025 | |
| Ascendis Pharma Endocrinology INC | $113.41 | 2025 | Yorvipath |
| Amneal Pharmaceuticals LLC | $92.33 | 2024-2025 | Unithroid |
| Teva Pharmaceuticals USA, INC. | $91.32 | 2021-2023 | Airduo Digihaler |
| Xeris Pharmaceuticals, INC. | $82.81 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $75.89 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $75.79 | 2021-2023 | Xywav |
| Tandem Diabetes Care, INC. | $74.11 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Antares Pharma, INC. | $68.32 | 2024-2025 | Xyosted |
| Genentech USA, INC. | $68.02 | 2022-2023 | Xolair |
| Madrigal Pharmaceuticals | $54.31 | 2025 | Rezdiffra |
| Mallinckrodt Hospital Products INC. | $49.85 | 2021-2023 | Acthar |
| Ani Pharmaceuticals, INC. | $49.61 | 2023 | Purified Cortrophin Gel |
| Amphastar Pharmaceuticals, INC. | $44.86 | 2025 | |
| Beta Bionics, INC. | $43.38 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbott Laboratories | $40.40 | 2025 | Freestyle Libre |
| Astellas Pharma US INC | $39.09 | 2025 | Veozah |
| Covis Pharma Gmbh | $38.90 | 2021 | |
| Esperion Therapeutics, INC. | $32.50 | 2024-2025 | Nexletol |
| Neurocrine Biosciences, INC. | $30.39 | 2025 | |
| Corcept Therapeutics | $27.15 | 2025 | Korlym |
| Phadia US INC. | $26.77 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $23.89 | 2025 | |
| Kyowa Kirin, INC. | $20.90 | 2025 | |
| Paratek Pharmaceuticals, INC. | $20.44 | 2021 | |
| Baxter Healthcare | $18.97 | 2023 | Hillrom - Life 2000 Ventilation System |
| Melinta Therapeutics, LLC | $18.49 | 2021 | |
| Philips North America LLC | $16.66 | 2021 | |
| Fisher & Paykel Healthcare INC | $14.26 | 2022 | |
| Biogen, INC. | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Velez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.